Dr Rajvir Dahiya
Dr Rajvir Dahiya is a scientific advisor and reviewer/ Chairman for the United States Army Department of Defense (DOD) Medical Research in the field of prostate cancer, breast cancer and ovarian cancer programs.
Dr Rajvir Dahiya, and his team of researchers, have discovered a new function of ribonucleic acid (RNA) for gene activation which may open new vistas in the treatment and prevention of various diseases, including cancer.[1]
Contents
Career
Rajvir Dahiya received his Ph.D. from the Post Graduate Institute of Medical Education and Research in the field of Experimental Medicine and Biochemistry. He completed four years of post-doctoral fellowship in the field of Oncology and Molecular Biology, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL. Dr. Dahiya joined the University of California San Francisco School of Medicine in 1987 as a Scientist at the Veterans Affairs Medical Center, San Francisco, CA. He became the Director of the Urology Research Center at the Veterans Affairs Medical Center and the University of California San Francisco School of Medicine in 1991. Currently, Dr. Dahiya is the Professor and Director of the Urology Research Center at the Veterans Affairs Medical Center and University of California San Francisco School of Medicine, San Francisco, California.
He is a member / Chairman of scientific review committees for the National Institutes of Health (NIH) including National Cancer Institute (NCI), National Institutes of Digestive Diseases and Kidney (NIDDK) and National Institute of Aging (NIA). As a committee member / Chairman, he reviews scientific progress and future plans for Comprehensive Cancer Center Programs, the George O’Brien Research Center, Specialized Programs for Research Excellence (SPORE); postdoctoral fellow training programs; program projects related to oncology and research projects related to urologic oncology.
Dr. Dahiya is a Medical Research advisor and scientific reviewer for the European Cancer Research Program “Fonds zur Forderung der Wissenschaftlichen Forschung”, Vienna, Austria. He is a Medical Research Consultant and scientific reviewer for Sheffield Hospitals Charitable Trust Medical Research Committee, The University of Sheffield, United Kingdom; Ministry of Science, Culture and Sport, Jerusalem, Israel; University Grant Committee, Hong Kong, China. Dr. Dahiya is a scientific collaborator and consultant for Kagoshima University Faculty of Medicine, Kagoshima, Japan; Hokkaido University School of Medicine, Sapporo, Japan; Hiroshima University School of Medicine, Hiroshima, Japan; Juntendo University School of Medicine, Tokyo, Japan; Osaka University Graduate School of Medicine, Osaka, Japan; Toho University School of Medicine, Tokyo, Japan; Shimane University Faculty of Medicine, Izumo, Japan; Seoul National University Hospital, Seoul, Korea; Chonnam University Medical School, Kwangju, Korea; and the University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Dr. Dahiya is the President of the International Cancer Research Association, the President of the Society of American Asian Scientists in Cancer Research and the President of the American Association of Indian Scientists in Cancer Research. The members of these associations are medical scientists from North America, South America, Europe and Asia. The purpose of these associations are to discuss the latest discoveries of our medical scientists, exchange novel ideas and foster collaboration among scientists in the field of early diagnosis and prognosis of cancers. Also to discuss future directions in the field of cancer prevention and treatment through novel strategies.
Dr. Dahiya has published over 200 original research manuscripts in national and international journals. He has written chapters in several books and holds multiple patents in the field of oncology. He has a long-standing interest in molecular genetics targets as novel biomarkers for the early diagnosis and prognosis of cancer.
Dr. Dahiya is a Program Director for many research projects. These include the Center for Excellence in Prostate Cancer funded by the Department of Veterans Affairs, Washington, DC; the Urological Research Training Program funded by NIH / NIDDK; VA Merit Review funded by the Department of Veterans Affairs, Washington, DC; DNA methylation in aging and prostate cancer program funded by NIA; Estrogen metabolizing genes and race-related prostate cancer funded by the NCI; genetic polymorphisms and prostate cancer program funded by the United States Army (DOD) Medical Research.
Highlights
- M.S., 1978, Kurukshetra University, India, Physiology / Biochemistry.
- Ph.D., 1983, Post Graduate Institute of Medical Education and Research, Chandigarh, India, Experimental Medicine / Biochemistry, Chairman: Nirmal Kumar Ganguly, M.D., FR, FAMS, FNA, FASC (Currently, Director-General, Indian Council of Medical Research).
- M.D., Kagoshima University Faculty of Medicine, Kagoshima, Japan, Oncology, Thesis on the Original Medical Research Contribution “Recent Advances in Cancer”; Chairman: Prof. Masayuki Nakagawa, M.D., Ph.D.; Dean: Prof. Hiromi Yoshida, M.D., Ph.D., Faculty of Medicine.
- D.Sc., University of Sao Paulo Faculty of Medicine, Sao Paulo, Brazil. Thesis on the Original Medical Research Contribution “Molecular Biology of Malignancies”; Chairman: Prof. Sami Arap, M.D., Ph.D.; Dean: Prof. Giovanni Guido Cerri, M.D., Ph.D., Faculty of Medicine.
- D.Sc., Osaka University Graduate School of Medicine, Osaka, Japan. Thesis on the Original Medical Research Contribution “Early Detection and Genetics of Cancer”; Chairman: Prof. Akihiko Okuyama, M.D., Ph.D., Dean: Prof. Koichi Yamanishi, M.D., Ph.D., Faculty of Medicine.
- D.Sc., Hokkaido University School of Medicine, Sapporo, Japan. Thesis on the Original Medical Research Contribution “Molecular Genetics and Epigenetics of Cancer”; Chairman: Prof. Noriaki Sakuragi, M.D., Ph.D., Dean: Prof. Shinzo Nishi, M.D., Ph.D., Faculty of Medicine.
- 1983-1987 Research Associate, Department of Medicine and Biochemistry, University of Chicago, Chicago, IL
- 1987-1993 Senior Scientist, Veterans Affairs Medical Center, University of California San Francisco School of Medicine, San Francisco, CA
- 1991-Present Director of Urology Research Center, Veterans Affairs Medical Center and University of California San Francisco School of Medicine, San Francisco, CA
- 1993-1997 Associate Professor, Department of Urology, University of California San Francisco School of Medicine, San Francisco, CA
- 1997-Present Professor, Department of Urology, University of California San Francisco School of Medicine, San Francisco, CA
U.S. Patent
- Tanagho, E.A., Dahiya, R., Lue, T.F., and Cunha, G.R. Smooth muscle tissue formation in vitro using cultured smooth muscle cells combined with an extracellular matrix. United States Patent # US 5,656,478 A; File date Feb. 25, 1994 ; approval date August 12, 1997 .
- Tanagho, E.A., Dahiya, R., Lue, T.F., and Cunha, G.R. Acellular matrix grafts: preparation and use. Unites States Patent # US 6,371,992 B1; File date December 9, 1997 ; approval date April 16, 2002 .
- Li, Long-cheng and Dahiya, R. Small activating RNA molecules and methods of use. United States Patent serial number 60/715,759; File date September 9th, 2005 .
Reference
Back to The Technocrats